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Abstract
Background: During its development, the parasite Schistosoma mansoni is exposed to different environments and
undergoes many morphological and physiological transformations as a result of profound changes in gene expression.
Characterization of proteins involved in the regulation of these processes is of importance for the understanding of
schistosome biology. Proteins containing zinc finger motifs usually participate in regulatory processes and are considered
the major class of transcription factors in eukaryotes. It has already been shown, by EMSA (Eletrophoretic Mobility Shift
Assay), that SmZF1, a S. mansoni zinc finger (ZF) protein, specifically binds both DNA and RNA oligonucleotides. This
suggests that this protein might act as a transcription factor in the parasite.
Methodology/Principal Findings: In this study we extended the characterization of SmZF1 by determining its subcellular
localization and by verifying its ability to regulate gene transcription. We performed immunohistochemistry assays using
adult male and female worms, cercariae and schistosomula to analyze the distribution pattern of SmZF1 and verified that
the protein is mainly detected in the cells nuclei of all tested life cycle stages except for adult female worms. Also, SmZF1
was heterologously expressed in mammalian COS-7 cells to produce the recombinant protein YFP-SmZF1, which was mainly
detected in the nucleus of the cells by confocal microscopy and Western blot assays. To evaluate the ability of this protein
to regulate gene transcription, cells expressing YFP-SmZF1 were tested in a luciferase reporter system. In this system, the
luciferase gene is downstream of a minimal promoter, upstream of which a DNA region containing four copies of the SmZF1
putative best binding site (D1-3DNA) was inserted. SmZF1 increased the reporter gene transcription by two fold (p#0.003)
only when its specific binding site was present.
Conclusion: Taken together, these results strongly support the hypothesis that SmZF1 acts as a transcription factor in S.
mansoni.
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Introduction
Schistosomiasis is a disease caused by trematode worms, mainly
Schistosoma mansoni, S. haematobium and S.japonicum. According to
World Health Organization, this parasitic disease affects 200
million people throughout the world [1]. Although the level of
schistosome-associated morbidity is unclear, some recent studies
have demonstrated that the illness is a more serious problem than
it was previously thought to be [2,3]. Therefore, emphasis should
be focused on mechanisms that could not only prevent, but also
cure schistosomiasis. A useful approach to fight the disease should
include infrastructure and educational components, as well as the
development of vaccines and new drugs [4]. Luckily we are living a
special moment, with the recent publication of both S. mansoni [5]
and S. japonicum [6] genomes, which will bring to the scientific
community an enormous amount of data to be mined in the search
for new therapeutic targets and vaccine development. Lastly,
additional effort should also be dedicated to studies regarding the
biology and development of the parasite.
During its life cycle, S. mansoni is exposed to different
environmental conditions: water, intermediate molluscan host,
and a definitive vertebrate host. As a consequence, this parasite
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and, as such, represents an interesting but challenging biological
system to investigate gene regulation processes [7–9]. A variety of
publications have focused on the identification and characteriza-
tion of S. mansoni stage-, tissue- and sex-specific/abundant proteins
and their coding genes [10–14], which may uncover hidden
aspects of parasite biology and thus provide useful leads for the
development of novel intervention strategies [7]. In a primary
analysis of the S. mansoni transcriptome, Verjovski-Almeida and
colleagues suggested that the number of differentially expressed
genes could reach as many as 1000 for each stage [15]. In more
recent publications, in which analyses of gene expression were
carried out using microarray, SAGE (Serial Analysis of Gene
Expression) and proteomic experiments, the authors confirmed a
number of sex- and stage-specific, differentially expressed genes
[8,16–26].
In order to better understand the transcriptional regulation of
S. mansoni genes, it is necessary to identify new transcription factors,
coactivators/corepressors and chromatin remodeling factors that
controlthis molecular process, along with regulatoryelements inthe
promoter region of genes [9]. Several efforts to describe new
transcription factors in this parasite have been made [27–31], but
given the complexity of its life cycle there are still many components
to be discovered and characterized. Zinc finger motifs are found in
several proteins amongst eukaryotic organisms and are key proteins
for transcription regulation [32–34]. SmZF1 is a S. mansoni 19 kDa
protein (GenBank accession number AAG38587) containing three
C2H2 type zinc finger motifs. Its cDNA was casually isolated from
an immune screening of a S. mansoni adult worm lambda gt11
expression library using an anti-tegumental serum. The transcript
coding for SmZF1 was also detected by PCR amplification in egg,
cercaria, schistosomulum and adult worm cDNA libraries,
suggesting that the protein is essential for metabolism during
different stages of the parasite life cycle [35]. In a previous work, we
used a recombinant SmZF1 protein in EMSA experiments to
investigate its binding capacity/specificity for DNA and RNA
oligonucleotides. SmZF1 was found to bind both double and single-
stranded DNA, as well as RNA oligonucleotides, but with about
10-fold lower affinity. Although we noticed that SmZF1 recognized
DNAand RNAoligonucleotidesnotcontainingputative targetsites,
theprotein bound preferentially to theones containingthe sequence
59-CGAGGGAGT-39 (oligonucleotide D1-3DNA). Furthermore,
unrelated oligonucleotides were not able to abolish this interaction.
Taken together, these initial results suggested that SmZF1 may act
as a putative transcription factor in S. mansoni [36].
In order to better characterize the biological function of the
SmZF1 protein, in this study we proposed to: (i) verify the
subcellular localization of SmZF1 in the cells of S. mansoni, as well
as in mammalian COS-7 cells expressing a recombinant YFP
(Yellow Fluorescent Protein)-SmZF1 protein; (ii) test the ability of
SmZF1 to activate or repress gene transcription. The results
described herein define SmZF1 as a S. mansoni nuclear protein
capable of activating gene transcription.
Materials and Methods
Anti-SmZF1 specific antibodies
In order to obtain anti-SmZF1 antibodies, the MBP (Maltose
Binding Protein) portion of a MBP-SmZF1 recombinant protein
[36] was cleaved using Factor Xa protease (New England Biolabs,
Ipswitch, MA, USA). The cleavage reaction was carried out for 48
ha t4 uC in a 1:25 enzyme: protein proportion. After digestion and
fractionation by electrophoresis, a Coomassie blue-stained protein
band (450 mg), representing the SmZF1 portion of the recombi-
nant protein was excised from a 10% SDS-PAGE, homogenized
with PBS (Phosphate Buffered Saline – 130 mM NaCl, 2 mM
KCl, 8 mM Na2HPO4, 1 mM KH2PO4), then emulsified with
Complete Freund Adjuvant and used for the primary intramus-
cular injection into a rabbit or with Incomplete Freund Adjuvant
for the two subsequent boosts (15 and 30 days after the first
immunization). Pre-immune serum was obtained before the first
immunization and rabbit serum containing anti-SmZF1 antibodies
was collected 15 days after the third immunization.
S. mansoni immunohistochemistry assays
S. mansoni adult worms used in this study were recovered from
perfused mice. Lung-stage schistosomula were prepared according
to Harrop and Wilson [37]. Cercariae were obtained from
Biomphalaria glabrata by exposing the infected snails to light for 2 h
to induce shedding of parasites.
Sections of Omnifix (AnCon Genetics Inc., Melville, NY, USA)
fixed, paraffin-embedded adult male or female worms were
deparaffinized using xylol, hydrated with an ethanol series,
washed in PBS and then incubated in a blocking solution
(0.05% Tween 20, 1% w/v BSA (Bovine Serum Albumin) in
PBS pH 7.2) overnight at 4uC. Samples were reacted for 1 h with
either the anti-SmZF1 or a control, pre-immune rabbit serum,
both diluted 1:30 in 10x diluted blocking solution. Sections were
then washed in PBS and reacted for 1 h with a 1:400 diluted goat
anti-rabbit IgG-Cy-5 conjugate (Jackson Immunoresearch Labo-
ratories Inc., West Grove, PA, USA) in 10x diluted blocking
solution, which also contained Alexa Fluor 488 phalloidin
(Invitrogen, Carlsbad, CA, USA) diluted 1:100 to stain actin
microfilaments (except for adult male worms). Afterwards, samples
were washed, incubated for 10 min with 1:3000 diluted propidium
iodide (Sigma-Aldrich, St. Louis, MO, USA) in 10x diluted
blocking solution to stain nuclei and then washed with PBS.
For experiments using cercariae and lung-stage schistosomula, a
whole-mount protocol was chosen. Omnifix fixed cercariae were
treated with a permeabilizing solution (0.1% Triton X-100, 1%
w/v BSA and 0.1% w/v sodium azide in PBS pH 7.4) for 3 h at
4uC under constant agitation. Subsequent immunostaining steps
used the same solution and condition. Samples were incubated
overnight with the anti-SmZF1 antibody diluted 1:90, washed
Author Summary
Schistosomes are parasites that exhibit a complex life cycle
during which they progress through many morphological
and physiological transformations. These transformations
are likely accompanied by alterations in gene expression,
making genetic regulation important for parasite devel-
opment. Here we describe a Schistosoma mansoni protein
(SmZF1) that may act as a parasite transcription factor.
These factors are key proteins for gene regulation. We
have previously demonstrated that SmZF1 is able to bind
DNA and that its mRNA is present at different stages
during the parasite life cycle. In this study we aimed to
define if this protein can function as a transcription factor
in S. mansoni. SmZF1 was detected in the nucleus of adult
male worms, cercariae and schistosomula cells. It was not,
however, observed in female cells, suggesting it to be
gender specific. We used mammalian cells expressing
recombinant SmZF1 to analyze if SmZF1 protein is able to
activate/repress gene transcription and demonstrated that
it increased the expression of a reporter gene by two-fold.
The results obtained confirm SmZF1 as a S. mansoni
transcription factor.
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IgG-Cy-5 conjugate diluted 1:1200 in solution containing Alexa
Fluor 488 phalloidin (1:500). The cercariae were then incubated
for 20 min with propidium iodide diluted 1:6000 and washed once
more. The schistosomulum immunohistochemistry assays were
carried out as with cercaria, with the following modifications: lung
stage schistosomula were treated with permeabilizing solution
overnight and then incubated with the anti-SmZF1 antibody (1:90)
for 2 h. The secondary antibody was used at a 1:1000 dilution, and
the phalloidin at a 1:100 dilution for 2 h.
Samples (adult male and female worms, schistosomula and
cercariae) were prepared with a mounting solution (90% glycerol,
10% tris-HCl 1 M, pH 8.0) and the fluorescence images were
captured with a Carl Zeiss LSM 510 META confocal microscope
using a 63x oil-immersion objective lens in the Center of Electron
Microscopy (CEMEL-ICB/UFMG). Images were analyzed with
Zeiss LSM Image Browser software and edited with Adobe
Photoshop CS.
All research protocols involving mice used in the course of this
study were reviewed and approved by the local Ethics Committee
on Animal Care at Universidade Federal de Minas Gerais
(CETEA – UFMG Nu 023/05).
RNA extraction and Real-Time PCR
Adult worms recovered from perfused mice were manually
separated and pooled according to their sex. Total RNA of both
male and female worms was extracted using Trizol reagent
(Invitrogen) and treated with DNase using Ilustra RNAspin
Mini RNA Isolation Kit (GE Healthcare, Waukesha, WI, USA)
according to the manufacturer’s instructions. RNA was then quan-
tified using a NanoDrop Spectrophotomer ND-1000 (Thermo
Scientific, Waltham, MA, USA). cDNA was synthesized using
0.3 to 1.0 mg total RNA and Superscript III First-Strand Syn-
thesis SuperMix for qRT-PCR (Invitrogen) according to the
manufacturer’s protocol. For q-PCR reactions, the primers
SmZF1_real2_forw (59–ACTTCTCTCAGAAATCCAGCCT–39)
and SmZF1_real2_rev (59–TGGAGAGGATTATACAATCTG-
GTT–39) were used at a 600 nM initial concentration. The
S. mansoni glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
gene (primers GAPDH_forw 59–TCGTTGAGTCTACTGGA-
GTCTTTACG–39 and GAPDH_rev 59–AATATGAGCCT-
GAGCTTTATCAATGG–39) was used as an endogenous control
in order to normalize relative amounts of total RNA. GAPDH
primers were used at a 900 nM initial concentration. The
amplicon sizes were 96 bp and 65 bp for SmZF1 and GAPDH,
respectively. q-PCR reaction mixtures consisting of 2.5 mlo f
cDNA, 12.5 ml of Power SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA) and 5 ml of each primer in a total
volume of 25 ml were added to 48-Well Optical Reaction Plates for
amplification and quantification in a StepOne Real-Time PCR
System (Applied Biosystems). Each q-PCR run was performed
with two internal controls in order to assess both potential genomic
DNA contaminations (i.e., no reverse transcriptase added in the
cDNA synthesis) and purity of the reagents used (i.e., no cDNA
added). Dissociation curve standard analyses were performed at
the end of each assay to certify the specific amplifying of targets.
For each set of primers, both male and female conditions
(including negative controls) were run in three technical replicates.
The experiment was repeated two times (biological replicates) and
the delta-delta Ct method [38] was used in order to make a relative
quantification comparing male and female transcript levels. Due to
the nonparametric distribution of data, statistical analysis of delta-
delta Ct values was performed using the Mann-Whitney U-test
with significance set at P,0.05.
Plasmid constructs and COS-7 cells culture
The SmZF1 cDNA was PCR amplified in a reaction mix-
ture prepared in a 50 mL final volume containing 25 ng of
template DNA, 0.2 pmol mL




TT-39 and SmZF1-stop-Hind: 59-CAGAAGCTTCATCCGGAA-
AGGCTTGAGA-39), 200 mM dNTPs and 5 U of Taq DNA
polymerase (Phoneutria, Belo Horizonte, MG, Brazil) in the
appropriate buffer (50 mM KCl, 10 mM Tris-HCl pH 8.4, 0.1%
Triton X-100, 1.5 mM MgCl2). The fragments obtained were
double-digested with XbaIa n dApaIo rSacIa n dHindIII restriction
enzymes (New England Biolabs) and purified using a Wizard SV Gel
and PCR Clean-up System (Promega, Madison, WI, USA) following
the manufacturer’s instructions. The fragments were then inserted,
respectively, into the commercial vectors pCDNA4/TO/myc-His
(Invitrogen) or pEYFP-c1 (Clontech, Mountain View, CA, USA),
generating the constructions pCDNA4-SmZF1 and pEYFP-SmZF1,
which express the recombinant proteins SmZF1-myc tag and YFP-
SmZF1, respectively. In addition, the viral thymidine kinase (tk)
promoter region was inserted (NheI/BglII) into the commercial vector
pGL3-basic (Promega), generating the vector pGL3-tk-luc, with the
luciferase (luc) reporter gene under control of the thymidine kinase
promoter. Subsequently, an oligonucleotide containing four repeti-
tions of the putative SmZF1 DNA binding site, D1-3DNA [36], was
inserted (KpnI/NheI) upstream of the minimal tk promoter, producing




binding sites D1-3DNA are indicated in bold).
Ligation products were used to transform the E. coli DH5a strain
and the rescued plasmids were sequenced using 10 pmol of
appropriate primers (for constructions based on pCDNA4/TO/
myc-His: CMV-fow 59-CGCAAATGGGCGGTAGGCGTG–39
and BGH-rev 59-TAGAAGGCACAGTCGAGG–39, for construc-
tions based on pEYFP-c1: YFP-fow 59-TTTTGCTCACAGGT-
TCT–39 and YFP-rev 59-GCCGTAGGTGGCATCGCC–39, for
constructions based on pGL3-basic: GLprimer2 59-CTTTAT-
GTTTTTGGCGTCTTCCA-39 and RVprimer3 59-CTAGCA-
AAATAGGCTGTCCC-39), 4 mL of DYEnamic ET Dye Termi-
nator Kit – MegaBACE (GE Healthcare) and 300 ng of DNA. The
sequencing products were analyzed in the MegaBACE 1000 DNA
Sequencer (GE Healthcare).
The above plasmid constructs were used either to transfect or
co-transfect COS-7 cells using Lipofectamine
TM 2000 Transfec-
tion Reagent (Invitrogen), according to the manufacturer’s
protocol. COS-7 cells were maintained at 37uC, 5% CO2 in
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented
with 10% fetal bovine serum and 1% glutamine (Invitrogen).
COS-7 cells fluorescence microscopy and Western blot
assays
The plasmids pEYFP-c1 (control) or pEYFP-SmZF1 were
transfected (as above) into COS-7 cells for transient protein
expression studies. Forty-eight hours after transfection the culture
medium was carefully removed and cells were fixed (15 min) with
3% paraformaldehyde in PBS, washed and then quenched using
PBS plus 10 mM NH4Cl (10 min). Cells were washed three times
with PBS and incubated for 7 min with 0.1% Triton X-100. After
another wash in PBS, COS-7 cells nuclei were stained (4 min)
with 5 mL of 1 mM Hoechst 33342 dye (Sigma-Aldrich). The
fluorescence was directly observed using a confocal microscope
The Transcription Factor SmZF1
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Quantix CCD camera controlled by MetaMorph imaging
software (MDS Analytical Technologies, Downingtown, PA,
USA).
For Western blot assays, COS-7 cells (0.5610
6) transfected
either with pCDNA4-SmZF1 or pEYFP-SmZF1 and control cells
transfected either with pEYFP or pCDNA were washed and
resuspended in 200 mL of cold TNE (150 mM NaCl, 50 mM Tris-
HCl pH 7.5 and 1 mM ethylenediaminetetraacetic acid (EDTA)).
A5 0mL aliquot of cells was centrifuged (700 g, 4 min, 4uC) and
the pellet resuspended in 50 mL of 2x SDS gel-loading buffer (100
mM Tris-HCl pH 6.8, 200 mM dithiothreitol, 4% SDS, 0.2%
bromophenol blue, 20% glycerol) and boiled for 5 min, generating
the total extract. The remaining 150 mL of cells was centrifuged
(700 g, 4 min, 4uC) and the pellet resuspended in 40 mL of lysis
buffer (10 mM Tris-HCl pH 7.5, 10 mM NaCl, 2 mM MgCl2,
1 mM phenylmethylsulphonylfluoride (PMSF), one dissolved
tablet of Complete Protease Inhibitor Cocktail (Roche, Basel,
Switzerland), 1 mM Na3VO4 and 1 mM NaF) plus 100 mLo f1 %
Nonidet P-40 (Sigma-Aldrich) in 50 mM Tris-HCl pH 7.5.
Samples were incubated in an ice bath for 10 min and centrifuged
(700 g, 4 min, 4uC). Ninety-five microliters of 5x SDS gel-loading
buffer was added to the supernatant, which was boiled for 5 min,
generating the cytoplasmic fraction. The pellet was washed twice
with cold TNE, centrifuged (700 g, 4 min, 4uC), resuspended in
50 mL of 2x SDS gel-loading buffer and boiled for 15 min,
generating the nuclear fraction. COS-7 total, cytoplasmic and
nuclear extracts, normalized at equal volume percentage, were
separated using 10% SDS-PAGE and blotted (2 h, 20 mA) onto
nitrocellulose membranes (Whatman GmbH, Dassel, Germany)
using a semi-dry blot system (GE healthcare). Antibody reactions
were performed as described by Koritschoner and colleagues [39].
Briefly, membranes were blocked overnight in TBS (25 mM Tris-
HCl pH 7.4, 137 mM NaCl, 5 mM KCl, 0.6 mM Na2HPO4, 0.7
mM CaCl2, 0.5 mM MgCl2) plus 1 mM EDTA, 1 mM Na3VO4,
0.05% Tween-20 and 3% BSA followed by two washes with 100
mM Tris-HCl pH 8.0, 200 mM NaCl, 0.2% Tween-20 (wash
buffer). Samples were reacted with anti-myc, anti-GFP or anti-c-
erbB-2 (1:1000) peroxidase conjugated antibodies (BD Biosciences,
Franklin Lakes, NJ, USA) in blocking buffer for 1 h. Subsequently,
blots were washed and developed with ECL enhanced chemilu-
minescence reagents (GE Healthcare) and exposed to X-ray film.
The exclusively cytoplasmic protein c-erbB-2 was used as a quality
control for extracts.
Electrophoretic mobility shift assay
For the electrophoretic mobility shift assay (EMSA), 20 pmol of
the D1-3DNA oligonucleotide (59-CGAGGGAGT-39) was incu-
bated with 1 mg of the total extract of COS-7 cells transfected with
plasmids pEYFP-c1 (control) or pEYFP-SmZF1. Extracts were
produced as follows: cells (0.5610
6) were washed in PBS and
resuspended in 100 mL of TDGK solution (20 mM Tris-HCl
pH 7.5, 2 mM dithiothreitol, 400 mM KCl, 5 mg/ml leupeptin,
5 mg/ml aprotinin, 20% glycerol, 0.5 mM PMSF, 1 mM
Na3VO4). Samples were maintained on ice for 30 min, centrifuged
(15000 g, 20 min, 4uC) and then the supernatant was collected.
Protein concentrations were measured and normalized as pre-
viously described [36]. The extract/DNA binding reactions were
carried out in a final volume of 15 mL of binding solution (4 mM
Tris-HCl pH 8.0, 40 mM NaCl, 1 mM ZnSO4, 4 mM MgCl2,5 %
glycerol) for 15 min at 4uC. For supershift reactions, the DNA/
extracts mixture was incubated, as above, with 1 mL of anti-GFP
or 2 mL of anti-SmZF1 antibodies. After incubations, samples
were fractionated in a 4% non-denaturing polyacrylamide gel in
TBE buffer (89 mM Tris-borate pH 8.0, 2 mM EDTA), at a
constant 25 mA at 4uC, to separate the bound complex from the
free oligonucleotides. The resulting gels were stained with
VISTRA Green DNA specific dye (GE Healthcare), according
to the manufacturer’s protocol.
Transient co-transfections and luciferase activity assays
Plasmid DNA co-transfections of COS-7 cells were carried out
in 24-well plates (Corning Inc., Corning, NY, USA). The day
before transfection, 8610
4 COS-7 cells were plated in 0.5 ml of
medium/well. For each well, 2 ml of LipofectamineTM 2000
Transfection Reagent were mixed with 1.2 mg of the plasmid DNA
of interest and 300 ng of TK-Renilla reporter plasmid in serum-
free Opti-MEM (Invitrogen) to allow the formation of DNA-
LipofectamineTM 2000 Transfection Reagent complexes. The
complexes were added to the respective wells and mixed by gently
rocking the plate back and forth. Cells were incubated in a 5%
CO2 incubator at 37uC for 48 h and then lysed with 60 mlo f
reporter lysis buffer (Promega). Luciferase activity (Relative Light
Units – RLU) was assayed with 20 ml of lysate and 80 mlo f
luciferase assay reagent (Promega) in a TD20/20 luminometer
(Promega) using a 10 s measurement period. Each transfection was
performed in triplicate. Transfection efficiency was normalized to
TK-Renilla luciferase reporter plasmid. Statistical analysis of the
data was carried out with Minitab Version 1.4 using Student’s
t test with Welch’s correction. Only p values,0.05 were con-
sidered as significant.
Results
SmZF1 has a nuclear localization at diverse S. mansoni
developmental stages
SmZF1 (GenBank accession AF316828) was initially identified
during a screen of an adult worm S. mansoni cDNA library [35].
Although it has also been detected in cDNA libraries of other
developmental stages of this parasite (i.e., egg, 3 h schistosomulum
and cercaria), the biological function of the protein coded by this
gene remains to be elucidated. The SmZF1 protein contains three
C2H2-type zinc finger motifs and binds specific DNA oligonucle-
otides, as do similar nuclear proteins involved in gene transcrip-
tional regulation [35,36]. Therefore, to investigate whether
SmFZ1 is present in the nucleus, where it could act as a
transcription factor, we decided to verify its subcellular localization
at diverse S. mansoni life stages.
We carried out in situ immunohistochemistry experiments using
an anti-SmZF1 antibody on S. mansoni collected at various stages
during its life cycle. Western blot assays using the recombinant
SmZF1 protein previously separated from its MBP portion, as well
as fractionated extracts form adult worms revealed that this
polyclonal antibody is specific to SmZF1 (Supporting information,
Figure S1). The immunohistochemistry assays showed that SmZF1
protein localizes in the cells nuclei of adult male worms
(Figures 1A–D), cercariae (Figures 1K–N) and lung stage
schistosomula (Figures 1P–S). Although we have performed three
different experiments in which we analyzed various paraffin
sections of female adult worms, the protein could not be detected
in this stage using this technique (Figures 1F–I and Supporting
information, Figure S2). No SmZF1 staining was observed in the
negative controls (Figures 1E, J, O, T) in which only the rabbit
pre-immune serum was used. These results suggest that SmZF1 is
a S. mansoni protein present in the nuclei of cells from diverse
developmental stages where it may act as a transcription factor.
Plus, SmZF1 expression might be sex-specific since it could not be
detected in adult female worms.
The Transcription Factor SmZF1
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female worms
We were unable to confirm the results from the immunohisto-
chemistry experiments showing differences in expression of
SmZF1 between male and female by Western blot, since nuclear
protein extraction from single sex pooled S. mansoni worms did not
provide sufficient material necessary for SmZF1 detection.
Therefore, we decided to verify gene expression by comparing
the transcript levels between adult male and female worms. Total
RNA extraction was performed in separate pools of male or female
worms and q-PCR analyses were carried out using primers
specifically designed for SmZF1 amplification. We detected no
difference in SmZF1 expression (p=0.22) between male and
female worms when comparing the amplification profile, indicat-
ing that the SmZF1 mRNA is equally present in both genders
(data not shown). These results suggest that although the SmZF1
gene is transcribed in female worms, a post-transcriptional
regulatory mechanism could be occurring to block SmZF1 protein
production in adult female worms.
SmZF1 goes to the nucleus when expressed in
mammalian cells
After demonstrating the nuclear localization of SmZF1 in S.
mansoni cells, the next step in the protein characterization was to
heterologously express it in a mammalian system to test its ability
to activate the transcription of a reporter gene. To accomplish this,
we initially transfected COS-7 cells with the pEYFP-SmZF1
construction and forty-eight hours after transfection, we verified
the presence of the YFP-SmZF1 recombinant protein mainly in
the cells nuclei using fluorescence microscopy. However, a low
level of fluorescent staining remained in the cytoplasm. In some
cases, the protein was also visualized as fibrous material in the
perinuclear region, probably associated with the cytoskeleton or
Golgi complex. The YFP protein (negative control) was visualized
diffusely distributed throughout the cells area (Figure 2A).
Since part of the fusion protein still remained in the cytoplasm of
the cells, a second construction lacking YFP (SmZF1-myc tag) was
used to confirm the SmZF1 nuclear localization in mammalian
cells. Western blot assays using equal amounts of total, cytoplasmic
Figure 1. Native SmZF1 displays a nuclear localization at diverse stages of S. mansoni development. Fixed parasites were incubated with
a rabbit anti-SmZF1 antibody, and then with a Cy-5 conjugated anti-rabbit IgG in a solution containing Alexa Fluor 488 phalloidin to stain actin
microfilaments (phalloidin staining was not used with adult male worms). Samples were incubated with propidium iodide to visualize cells nuclei.
Fluorescent images were obtained using a 63x oil-immersion objective lens and confocal microscopy (Carl Zeiss LSM 510 META). Images were
analyzed with the Zeiss LSM Image Browser software and edited with Adobe Photoshop CS. To help distinguish the individual fluorescence signals,
the original fluorescence colors were digitally modified. In the figure, fluorescence from Cy-5 is shown in red, propidium iodide in blue and phalloidin-
Alexa fluor 488 in green. The merged blue and red produces a pink color. For adult male worms a phase contrast image is also presented. The
following developmental stages were assayed: adult male (A–D) and female (F–I) worms, cercaria (K–N) and schistossomulum (P–S). Rabbit pre-
immune serum was used as a control and was negative in all samples (E, J, O and T). Bars=20 mm.
doi:10.1371/journal.pntd.0000547.g001
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YFP-SmZF1 or SmZF1-myc tag were performed. Fractions were
analyzed using either anti-GFP (which also recognizes YFP) or anti-
mycantibodies (Figure2B). Theresults corroboratedthoseobtained
by fluorescence microscopy (Figure 2A), showing that YFP-SmZF1
is present in both nuclear and cytoplasmic extracts, with a slight
enrichment of the protein in the nuclear extract (Figure 2B).
However, the recombinant protein SmZF1-myc tag is only present
in the nuclear COS-7 extract, suggesting that YFP may be
interfering in the transport of the fusion protein to the nucleus.
The quality of the fractionation was confirmed by the localization of
the cytoplasmic protein c-erbB-2 in the total and cytoplasmic
fractions only (Figure 2B).
YFP- SmZF1 is able to bind specific DNA oligonucleotides
and activate transcription in COS-7 cells
In previous experiments using purified recombinant SmZF1
protein expressed in bacteria, we demonstrated the nucleic acid
binding ability and specificity of SmZF1, its preference for DNA as
compared to RNA, and its putative best DNA binding sequence
(D1-3DNA) [36].
To verify whether the recombinant protein YFP-SmZF1
expressed in mammalian COS-7 cells was able to interact with
D1-3DNA binding site in a manner comparable to its recombi-
nant prokaryotic counterpart, EMSA assays were performed.
Total extracts of COS-7 cells transfected with either pEYFP-c1 or
pEYFP-SmZF1, expressing YFP or YFP-SmZF1, respectively,
were incubated with the D1-3DNA oligonucleotide. To confirm
the SmZF1/D1-3DNA interaction, supershift assays using anti-
GFP and anti-SmZF1 antibodies were also performed. Extracts of
cells expressing the YFP-SmZF1 recombinant protein were able to
shift the oligonucleotide migration in the gel (Figure 3, lane 5).
Additionally, both anti-GFP and anti-SmZF1 antibodies were able
to supershift D1-3DNA migration, confirming that the YFP-
SmZF1 protein was responsible for the oligonucleotide binding
(Figure 3, lanes 6 and 7). Extracts of cells expressing only the YFP
protein (Figure 3, lanes 2–4), as well as anti-GFP and anti-SmZF1
antibodies (Figure 3, lanes 8 and 9), were not able to shift the
D1-3DNA migration.
Although new vectors which will allow transfection of
schistosome cells are under development [40–42], it is still not
possible to continuously cultivate schistosome cells lineages in vitro.
Accordingly, some authors describe the use of mammalian cells to
study aspects of S. mansoni gene regulation processes, such as
testing transcription factor activities or mapping promoter regions
of genes [28,43,44]. Thus, a luciferase system assay in COS-7
Figure 2. SmZF1 has a nuclear localization in COS-7 cells. (A) COS-7 cells were transfected either with pEYFP-c1 (control) or pEYFP-SmZF1
plasmids for transient expression of the proteins YFP or YFP-SmZF1. After 48 h the cells were fixed with paraformaldehyde, quenched, permeabilized
and the cells nuclei stained using Hoechst 33342 dye. Images were directly captured at 200x magnification using Carl Zeiss LSM 510 META. In order to
obtain a clearer visualization of fluorescent signals in merged images, the original yellow fluorescence of YFP and blue fluorescence of Hoechst were
modified to green and red, respectively, using Adobe Photoshop CS2. (B) SmZF1-transfected and control COS-7 cells were used to generate the total
(TE), cytoplasmic (CE) and nuclear (NE) extracts. The extracts were submitted to 10% SDS-PAGE and blotted onto nitrocellulose membranes.
Membranes were blocked overnight and samples were reacted with anti-myc, anti-GFP or anti-c-erbB-2 peroxidase conjugated antibodies (1:1000).
Subsequently, blots were washed and developed with ECL enhanced chemiluminescence reagents and exposed to X-ray films. The exclusively
cytoplasmic human oncoprotein c-erbB-2 was used as a quality control for extracts. YFP can be visualized as an approximately 30 kDa protein and the
recombinant protein YFP-SmZF1 as an approximately 50 kDa protein.
doi:10.1371/journal.pntd.0000547.g002
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here to test SmZF1ability to regulate gene transcription.COS-7
cells co-transfected with the expression vector pEYFP-SmZF1 and
the construction pGL3-zf-tk-luc, which contains four repetitions of
the SmZF1 D1-3DNA binding site and a thymidine kinase
minimal promoter upstream of the luciferase coding gene, were
able to increase gene transcription by 2-fold (p#0.003) when
compared to negative controls, using the Student’s t test (Figure 4).
These results suggested that SmZF1 positively affects the
transcriptional activity of the minimal thymidine kinase promoter
in COS-7 cells.
Discussion
Schistosomiais is one of 13 neglected tropical diseases that
together affect 1 billion people worldwide. The disease is considered
the second most socioeconomically devastating parasitic disease,
the first being malaria [45]. According to Chirac and Torreele, in
the past 30 years the number of drugs which target these neglected
diseases is about 1% of all the new chemical entities commercialized
by the pharmaceutical industry [46].
S. mansoni presents a variety of interesting biological regulatory
processes, such as transcriptional control, which can be used to
allow its adaptation to the diverse biotic and abiotic environments
[8]. Description of genes expressed in a stage- or sex-specific
manner may help to elucidate the events used by the parasite to
deal with these potentially adverse conditions. In turn, this
information may also help to develop suitable vaccines and
chemotherapeutic drugs against this organism [7]. As stated in the
recent and high quality review on schistosome genomics by Han
and colleagues [47], some potential drug targets should include
proteins involved in DNA replication, transcription and repair
systems. This suggestion is also corroborated by a chemogenomics
screening approach described as part of the up-to-date S. mansoni
genomic analysis, in which the authors used a strategy to find
significant matches between parasite proteins and proteins known
to be targets for drugs in humans and human pathogens. That
study revealed 26 putative S. mansoni protein targets and their
potential drugs. Of these 26 targets, three proteins are involved in
DNA metabolism and two others are involved in chromatin
modification (histone deacetylase 1 and 3) [5]. These two examples
emphasize the importance of nuclear proteins as potential drug
targets.
According to the authors of the S. mansoni transcriptome project
[48], 2.4% of the categorized ESTs (Expressed Sequence Tags)
under the Molecular Function in Gene Ontology (GO) encode
transcriptional regulators. A search for conserved domains using
the Pfam database in a subset of those transcripts showed that 5%
Figure 3. SmZF1 heterologously expressed in COS-7 cells is
able to bind to its target oligonucleotide. For EMSA experiments,
SmZF1 target oligonucleotide D1-3DNA was incubated with no extract
(lane 1) or total extracts of COS-7 cells expressing the proteins YFP
(lanes 2–4) or YFP-SmZF1 (lanes 5–7). For supershift reactions, the
mixture DNA/extracts was pre-incubated with anti-GFP (lanes 3 and 6)
or anti-SmZF1 antibodies (lanes 4 and 7). As negative controls, the anti-
GFP and anti-SmZF1 antibodies were also incubated with the
oligonucleotide in the absence of cell extracts (lanes 8 and 9,
respectively). The resulting 4% PAGE was stained with VISTRA Green
DNA specific dye for visualization of bands.
doi:10.1371/journal.pntd.0000547.g003
Figure 4. SmZF1 is able to increase luciferase gene expression
in COS-7 cells. The plasmids of interest plus the TK-Renilla reporter
plasmid were transfected into COS-7 cells using the LipofectamineTM
2000 Transfection Reagent. Each transfection was performed in
triplicate, and transfection efficiency was normalized to TK-Renilla
luciferase reporter plasmid. Luciferase activity was assayed in cell lysates
using a TD20/20 luminometer (Promega) and is indicated as Relative
Light Units (RLU). Statistical analysis of the data was carried out with
Minitab Version 1.4 using Student’s t test, and p values,0.05 were
considered as significant. Data is representative of three independent
experiments.
doi:10.1371/journal.pntd.0000547.g004
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most of the 15 Pfam domains found were from proteins involved in
either intercellular communication or transcriptional regulation.
These findings reinforce the importance of this class of regulatory
proteins for S. mansoni biology. In addition, using the SAGE
approach, Ojopi and colleagues found that 9.7% of the most
abundant genes (genes containing more than 500 tags) from
S. mansoni adult worms comprise those from the nucleic acid
binding GO functional category [49].
The present study defines the SmZF1 protein as a S. mansoni
transcription factor. SmZF1 is a C2H2 zinc finger protein able to
specifically bind to RNA and DNA, but with higher affinity for
DNA molecules. Its transcript was identified in the cercaria, egg,
schistosomulum and adult worm stages, suggesting its importance
as a regulatory protein [35,36].
To define SmZF1 activity as a transcription factor, we first
verified its subcellular localization, since this class of proteins is
preferentially located or able to go to the cell nucleus, this import
being a central step to regulate gene transcription [50,51]. In silico
analyses of the SmZF1 amino acid sequence did not predict any
classical potential nuclear localization signal (NLS), but did reveal
positively charged amino acids within the zinc finger motifs [35]. It
has been demonstrated that zinc finger motifs are sufficient and
sometimes essential for nuclear localization of ZF proteins, even
without any canonical NLS detected in their amino acid sequences
[51,52]. Moreover, it is well known that small proteins (,40 Kda),
like SmZF1, are sometimes able to passively diffuse into the
nucleus [50].
Immunohistochemical analysis of the diverse parasite develop-
mental stages demonstrated that SmZF1 was indeed localized in
the nucleus of S. mansoni cercariae, schistosomula and adult male
worms. This confirms previous results obtained by SmZF1 cDNA
amplification [35] and reinforces our hypothesis that the protein is
a transcription factor. An unexpected result was the lack of
detection of SmZF1 protein in adult female worms when assayed
by this technique. This differs from available transcriptome data,
given the existence of one EST sequence (GenBank accession
number BF936884) derived from an adult female worm cDNA
library presenting 99% identity with SmZF1. Also, studies using
oligonucleotide microarrays in which the SmZF1 sequence was
spotted on the slide did not reveal this transcript as being
differentially expressed between adult male and female worms
[16,20]. Based on these observations, we performed q-PCR
experiments to analyze the SmZF1 mRNA expression. We were
not able to detect differences in the levels of SmZF1 transcripts
between adult male and female worms, indicating that the SmZF1
gene is being equally transcribed in adult female as it is in adult
male worms. The fact that SmZF1 protein was not detected in
adult female worms by immunofluorescence experiments suggests
that a post-transcriptional mechanism regulates the gene. It is
important to note that, apparently, SmZF1 mRNA levels are low
in all parasite life cycle stages, as demonstrated by the number of
ESTs matching SmZF1 cDNA present at dbEST (Table S1). Since
the SmZF1 protein is highly abundant at the various stages, as
verified by immunohistochemistry assays (except for the female
adult worm), it can be hypothesized that the protein has a long half
life and that the few existing mRNAs may possess a high
translational rate. However, this picture might be different for
female adult worms, in which the transcript could be less
translated or translated in a non-efficient way. As a second
hypothesis, the protein in females may present a higher turnover.
Future experiments need to be done in order to clarify these
points. In a recent study concerning S. japonicum, Liu and
colleagues analyzed data obtained using either transcriptome or
proteome approaches and found several genes with no direct
correlation in their expression when comparing these two
techniques [53]. The authors explained this fact by limitations in
sensitivity of the proteomic technologies they employed, but also
highlighted that some transcripts may be relatively stable,
persisting throughout several stages and being translated in a
shorter window. This could contribute to the discrepancy between
the proteomic and transcriptomic data [53].
According to Hokke and colleagues, investigating proteins
differentially associated with each sex could reveal important clues
concerning the formation of sexually mature schistosomes and
consequently leading to the description of novel chemotherapeutic
targets acting in the maturation process [54]. Recently, different
groups have used a myriad of approaches to describe schistosome
genes expressed in a gender- or stage-enriched/specific fashion,
emphasizing the importance of identification and characterization
of proteins that may be controlling the transcription of these genes
[8,16–26]. Moreover, the sex-specific presence of a protein
potentially capable of regulating the expression of a large number
of other genes, as in the case of SmZF1, becomes undoubtedly
important in this context. One molecule, SmLIMPETin appears
to modulate gene expression in S. mansoni [55]. SmLIMPETin gene
is less expressed in sexually mature adult females when compared
to sexually immature adult females and sexually mature and
immature adult males [55]. These observations suggest that the
sex-specific expression of a transcription factor may be a common
feature involved in the maintenance of this parasite life cycle.
The ability of SmZF1 to activate/repress transcription of a
luciferase reporter gene in a cellular context was assessed using
COS-7 cells. The first step was to confirm the expression,
localization and activity of the fusion protein YFP-SmZF1, used
for the assay. YFP-SmZF1 was clearly visualized in the COS-7
cells nuclei using fluorescent microscopy; however, the protein was
also visualized as fibrous filaments dispersed at the perinuclear
region, probably associated with the cells cytoskeleton. Further-
more, Western blot assays showed the preferential nuclear
localization for YFP-SmZF1, although it was also detected to a
lesser degree in the cytoplasmic extract fraction. One possible
explanation for this finding is that the YFP portion of the fusion
protein, considering its larger size, is interfering with the efficiency
of its transport to the nucleus. Conversely, recombinant SmZF1-
myc tag, a smaller protein, is detected exclusively in the nuclear
portion of COS-7 cells.
The second step was to verify the protein activity, i.e., if the
recombinantproteinYFP-SmZF1 wasableto bind toitstargetDNA.
EMSA assays were performed using total COS-7 extracts incubated
with the putative SmZF1 best binding sequence, D1-3DNA. The
experiments showed that cell extracts expressing the YFP-SmZF1
recombinant protein retarded the migration of D1-3DNA in the gel.
When anti-GFP or anti-SmZF1 antibodies were added to the extract-
DNA samples, a supershift was observed, confirming the binding of
YFP-SmZF1 to its target.
The transcriptional activity of SmZF1 was further tested using a
luciferase reporter system. The results showed a 2-fold increase on
the luciferase gene expression in COS-7 cells co-transfected with
pGL3-zf-tk-luc and pEYFP-SmZF1. The small but significant
increase in the luciferase gene expression observed might be due to
the absence, in COS-7 cells, of additional proteins that are
important for the proper arrangement of the transcriptional
complex into the promoter region. Supporting this hypothesis,
Emami and colleagues found that a species-specific interaction
between TFIID and Sp1 was essential for transcriptional
activation, thus suggesting a difference in transcriptional machin-
ery between vertebrates and invertebrates [56]. As for SmZF1, if a
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activation would probably be much more substantial. A similar
scenario has been reported for the protein SmNR1 from S.
mansoni. In a recent work, Wu and colleagues demonstrated that
the SmNR1 protein alone is able to activate the transcription of a
reporter gene in COS-7 cells, but when another protein already
known to interact with it (SmRXR1) is present, this activation
increases approximately 2-fold [28]. In order to better characterize
SmZF1 action as a transcription factor, future experiments
designed to detect the protein binding partners will be necessary.
In addition to the DNA/RNA specific binding ability of SmZF1
[36], the evidence of its nuclear localization, as well as its capacity
to activate gene transcription, strongly suggest that SmZF1 is a S.
mansoni transcriptional regulator. Additional experiments aimed at
determining SmZF1 biological role are being performed. Recently
our group used RNAi to conduct an in vitro phenotypic screening
of 32 S. mansoni genes, including SmZF1, known to be expressed at
the sporocyst stage [57]. In this study, miracidia were cultivated in
vitro, transformed into sporocysts in the presence of specific
dsRNAs and observed during 7 days, in order to evaluate
phenotypic changes. The treatment of the S. mansoni larvae with
SmZF1-dsRNA induced a reduction of 30% on the SmZF1
transcript levels, when assayed by q-PCR. This modest reduction
on the transcript levels was accompanied by a shortening at the
sporocyst length in two out of three independent experiments,
when compared to a negative control in which a GFP-dsRNA was
used. These results show that, even with a small reduction at the
transcript levels the parasite phenotype was altered, demonstrating
the importance of the SmZF1 gene expression for the parasite
larval stage. We believe that the significance of these findings can
be extended for the other life cycle stages.
Supporting Information
Figure S1 Anti-SmZF1 polyclonal antibody recognizes the
SmZF1 protein. S. mansoni fractionated protein extracts, as well as
the recombinant MBP-SmZF1 protein previously cleaved from its
MBP portion, weresubmitted toSDS - PAGE10%and blotted onto
a nitrocellulose membrane. The anti-SmZF1 antibody was used to
specifically recognize the protein. TE - total extract, NE - nuclear
extract, CE - cytoplasmic extract.
Found at: doi:10.1371/journal.pntd.0000547.s001 (3.71 MB TIF)
Figure S2 The SmZF1 protein could not be detected in female
adult worm body sections by immunohistochemistry assays.
Sections of S. mansoni fixed female adult worms were incubated
with a rabbit anti-SmZF1 antibody, and then with a Cy-5
conjugated anti-rabbit IgG in a solution containing Alexa Fluor
488 phalloidin to stain actin microfilaments. Samples were
incubated with propidium iodide to visualize cells nuclei.
Fluorescent images were obtained using a 63x oil-immersion
objective lens and confocal microscopy (Carl Zeiss LSM 510
META). Images were analyzed with the Zeiss LSM Image
Browser software and edited with Adobe Photoshop CS. To help
distinguish the individual fluorescence signals, the original
fluorescence colors were digitally modified. In the figure,
propidium iodide fluorescence is shown in blue and phalloidin-
Alexa fluor 488 in green.
Found at: doi:10.1371/journal.pntd.0000547.s002 (0.67 MB TIF)
Table S1 Frequency of ESTs matching SmZF1 cDNA at the
diverse S. mansoni life cycle stage libraries at UniGene.
Found at: doi:10.1371/journal.pntd.0000547.s003 (0.04 MB
DOC)
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